Medical Device Network on MSN1d
FDA clears Caristo’s AI-powered CAD diagnostic software
The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.
AOL5d
How a new FDA-approved drug can — and can’t — help people with Alzheimer’s
Leqembi has been shown to successfully reduce amyloid plaques in the brain. (It’s actually the second drug shown to do this; the first one was Aduhelm.) Amyloid plaque is a substance that may ...
Mena FN6d
Biocon Biologics Announces Positive Results From Phase 3 Study Of Yesintektm Biosimilar To Ustekinumab For Chronic Plaque Psoriasis
YESINTEK has been approved by the US FDA for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic ...